education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Bifotik
Bifotik
cefoperazone
Manufacturer:
Sanbe
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Cefoperazone Na
Indications/Uses
Infection of resp tract, peritonitis & other intra-abdominal infections, septicaemia, skin & soft tissue infection, UTI, GUT infections, endometritis.
Dosage/Direction for Use
Adult
2-4 g daily IM/IV at 12 hr intervals.
Severe infections
6-12 g daily in 2-4 divided doses.
Contraindications
Hypersensitivity to cephalosporins.
Special Precautions
GI disorder (colitis), vit K deficiency. Pregnancy & lactation.
Adverse Reactions
Skin reactions, fever, hematological changes, increased hepatic enzyme function, diarrhea, nausea, vomiting, pseudomembranous colitis, pain at the inj site, phlebitis.
View
ADR Reporting Link
Drug Interactions
Potentially nephrotoxic substances, aminoglycosides.
MIMS Class
Cephalosporins
ATC Classification
J01DD12 - cefoperazone ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Regulatory Classification
K
Presentation/Packing
Form
Bifotik powd for inj 1 g
Packing/Price
(vial) 1's (Rp193,600/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk